PharmaTher Holdings Ltd. PHRRF
0.04 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.039 Day range 0.0403
0.032 52-week range 0.121
- YTD
- -42.86%
- 1 year
- -46.67%
- Market cap
- 3.64M
- EPS (ttm)
- -0.01
- YTD return
- -42.86%
- 1-year return
- -46.67%
- Volume
- 153.99K
- Avg volume
- 112.83K
- Open
- 0.039
- Previous close
- 0.04
- Day's range
- 0.039 – 0.0403
- 52-week range
- 0.032 – 0.121
2Y -0.1330 (-76.88%)
News
PharmaTher Builds Portfolio of Personalized, 3D-Printed Peptide Products for New U.S. Peptide Pathway, Led by Colon-Targeted KPV and BPC-157 
PharmaTher Submits Orphan Drug and Rare Pediatric Disease Designation Applications to FDA for 3D-Printed Creatine Monohydrate in GAMT Deficiency 
PharmaTher Outlines Corporate Strategy and Upcoming Milestones; Launches New Corporate Website and Rebrands PERSONALIZ3D as M3DICINES 
PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform 
PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Shares Shorted: Short Interest Up 98.5% in September 
PharmaTher Establishes PERSONALIZ3D(TM) to Commercialize a Personalized Medicine Platform Combining Telehealth and Pharmaceutical 3D Printing 
PharmaTher Collaborates with Craft Health to Evaluate CraftMake(TM) GMP-Ready Pharmaceutical 3D Printing Platform for Personalized Peptides 
PharmaTher Launches Personaliz3D Peptides(TM) to Advance Personalized Peptide Care Following Positive FDA Advisory Committee Recommendations 
PharmaTher Enters into Collaboration Agreement for KetaMist(R) to Advance Needle-Free Ketamine Treatment Toward FDA Approval 
PharmaTher Updates Strategy on Personalized Medicines for Peptides and Psychedelics
Your note
Sign in to keep a note on PHRRF — it syncs with the Stock Master app.